Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Vollenweider, FX' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 31 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Frei, E; Gamma, A; Pascual-Marqui, R; Lehmann, D; Hell, D; Vollenweider, FX
      Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)

      HUMAN BRAIN MAPPING
    2. Vollenweider, FX; Jones, RT; Baggott, MJ
      Response: Caveat emptor: Editors beware

      NEUROPSYCHOPHARMACOLOGY
    3. Liechti, ME; Geyer, MA; Hell, D; Vollenweider, FX
      Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

      NEUROPSYCHOPHARMACOLOGY
    4. Gamma, A; Buck, A; Berthold, T; Vollenweider, FX
      No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine)users and control subjects: A [(H2O)-O-15]-positron emission tomography study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    5. Liechti, ME; Gamma, A; Vollenweider, FX
      Gender differences in the subjective effects of MDMA

      PSYCHOPHARMACOLOGY
    6. Gamma, A; Frei, E; Lehmann, D; Pascual-Marqui, RD; Hell, D; Vollenweider, FX
      Mood state and brain electric activity in Ecstasy users

      NEUROREPORT
    7. Liechti, ME; Vollenweider, FX
      Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    8. Gamma, A; Buck, A; Berthold, T; Liechti, ME; Vollenweider, FX
      3,4-methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [(H2O)-O-15]-PET in healthy humans (vol 23, pg 388, 2000)

      NEUROPSYCHOPHARMACOLOGY
    9. Gamma, A; Buck, A; Berthold, T; Hell, D; Vollenweider, FX
      3,4-methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [(H2O)-O-15]-PET in healthy humans

      NEUROPSYCHOPHARMACOLOGY
    10. Liechti, ME; Saur, MR; Gamma, A; Hell, D; Vollenweider, FX
      Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans

      NEUROPSYCHOPHARMACOLOGY
    11. Liechti, ME; Baumann, C; Gamma, A; Vollenweider, FX
      Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

      NEUROPSYCHOPHARMACOLOGY
    12. Buck, A; Gucker, PM; Schonbachler, RD; Arigoni, M; Kneifel, S; Vollenweider, FX; Ametamey, SM; Burger, C
      Evaluation of serotonergic transporters using PET and [C-11](+)McN-5652: Assessment of methods

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    13. Liechti, ME; Vollenweider, FX
      The serotonin uptake inhibitor citalopram reduces acute cardiovascular andvegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    14. Vollenweider, FX; Vontobel, P; Oye, I; Hell, D; Leenders, KL
      Effects of (S)-ketamine on striatal dopamine: a [C-11]raclopride PET studyof a model psychosis in humans

      JOURNAL OF PSYCHIATRIC RESEARCH
    15. Vollenweider-Scherpenhuyzen, MFI; Vollenweider, FX
      Emergency cases in drug abuse

      INTERNIST
    16. Umbricht, D; Schmid, L; Koller, R; Vollenweider, FX; Hell, D; Javitt, DC
      Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers - Implications for models of cognitive deficits in schizophrenia

      ARCHIVES OF GENERAL PSYCHIATRY
    17. Vollenweider, FX; Gamma, A; Liechti, M; Huber, T
      Is a single dose of MDMA harmless?

      NEUROPSYCHOPHARMACOLOGY
    18. Vollenweider, FX; Vontobel, P; Hell, D; Leenders, KL
      5-HT modulation of dopamine release in basal ganglia in psilocybin-inducedpsychosis in man - A PET study with [C-11]raclopride

      NEUROPSYCHOPHARMACOLOGY
    19. Zessin, J; Gucker, P; Ametamey, SM; Steinbach, J; Brust, P; Vollenweider, FX; Johannsen, B; Schubiger, PA
      Efficient synthesis of enantiomerically pure thioester precursors of [C-11]McN-5652 from racemic McN-5652

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    20. Vollenweider, FX; Remensberger, S; Hell, D; Geyer, MA
      Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans

      PSYCHOPHARMACOLOGY
    21. Vollenweider, FX; Vollenweider-Scherpenhuyzen, MFI; Babler, A; Vogel, H; Hell, D
      Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

      NEUROREPORT
    22. VOLLENWEIDER FX; MAGUIRE RP; LEENDERS KL; MATHYS K; ANGST J
      EFFECTS OF HIGH AMPHETAMINE DOSE ON MOOD AND CEREBRAL GLUCOSE-METABOLISM IN NORMAL VOLUNTEERS USING POSITRON-EMISSION-TOMOGRAPHY (PET)

      PSYCHIATRY RESEARCH-NEUROIMAGING
    23. VOLLENWEIDER FX; VONTOBEL P; LEENDERS KL; HELL D
      5-HT STIMULATION INCREASES BASAL GANGLIA DOPAMINE RELEASE IN HUMAN-MODEL PSYCHOSIS - A PET STUDY WITH [11C]RACLOPRIDE

      Schizophrenia research
    24. VOLLENWEIDER FX; GAMMA AG; LIECHTI M; HUBER T
      PSYCHOLOGICAL AND CARDIOVASCULAR EFFECTS AND SHORT-TERM SEQUELAE OF MDMA (ECSTASY) IN MDMA-NAIVE HEALTHY-VOLUNTEERS

      Neuropsychopharmacology
    25. AMETAMEY S; VOLLENWEIDER FX; PATT J; BOURQUIN D; HASLER F; BEER HF; SCHUBIGER PA
      C-11 RADIOLABELING OF HALLUCINOGENIC PSILOCIN, A POTENTIAL RADIOLIGAND FOR STUDYING THE ROLE OF SEROTONIN RECEPTORS IN PSYCHOTIC SYMPTOM FORMATION

      Journal of labelled compounds & radiopharmaceuticals
    26. VOLLENWEIDER FX
      ADVANCES AND PATHOPHYSIOLOGICAL MODELS OF HALLUCINOGENIC DRUG ACTIONSIN HUMANS - A PREAMBLE TO SCHIZOPHRENIA RESEARCH

      Pharmacopsychiatry
    27. Vollenweider-Scherpenhuyzen, MFI; Vollenweider, FX
      Emergencies involving drug poisoning

      ANAESTHESIST
    28. VOLLENWEIDER FX; LEENDERS KL; SCHARFETTER C; ANTONINI A; MAGUIRE P; MISSIMER J; ANGST J
      METABOLIC HYPERFRONTALITY AND PSYCHOPATHOLOGY IN THE KETAMINE MODEL OF PSYCHOSIS USING POSITRON EMISSION TOMOGRAPHY (PET) AND [F-18] FLUORODEOXYGLUCOSE (FDG)

      European neuropsychopharmacology
    29. VOLLENWEIDER FX; LEENDERS KL; OYE I; HELL D; ANGST J
      DIFFERENTIAL PSYCHOPATHOLOGY AND PATTERNS OF CEREBRAL GLUCOSE-UTILIZATION PRODUCED BY (S)-KETAMINE AND (R)-KETAMINE IN HEALTHY-VOLUNTEERS USING POSITRON EMISSION TOMOGRAPHY (PET)

      European neuropsychopharmacology
    30. VOLLENWEIDER FX; LEENDERS KL; SCHARFETTER C; MAGUIRE P; STADELMANN O; ANGST J
      POSITRON EMISSION TOMOGRAPHY AND FLUORODEOXYGLUCOSE STUDIES OF METABOLIC HYPERFRONTALITY AND PSYCHOPATHOLOGY IN THE PSILOCYBIN MODEL OF PSYCHOSIS

      Neuropsychopharmacology
    31. FENG N; VOLLENWEIDER FX; MINDER EI; RENTSCH K; GRAMPP T; VONDERSCHMITT DJ
      DEVELOPMENT OF A GAS-CHROMATOGRAPHY - MASS-SPECTROMETRY METHOD FOR DETERMINATION OF KETAMINE IN PLASMA AND ITS APPLICATION TO HUMAN SAMPLES

      Therapeutic drug monitoring


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:25:59